| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 371.08B | 362.69B | 339.37B | 350.67B | 300.92B | 278.44B |
| Gross Profit | 123.19B | 119.65B | 113.93B | 119.94B | 113.54B | 115.59B |
| EBITDA | 38.04B | 38.59B | 37.87B | 48.06B | 50.59B | 29.86B |
| Net Income | 15.18B | 16.20B | 16.18B | 21.21B | 20.77B | 10.57B |
Balance Sheet | ||||||
| Total Assets | 470.12B | 477.59B | 437.47B | 399.17B | 362.44B | 306.92B |
| Cash, Cash Equivalents and Short-Term Investments | 62.09B | 83.30B | 95.08B | 96.82B | 81.62B | 67.38B |
| Total Debt | 52.54B | 65.60B | 47.80B | 44.56B | 53.75B | 43.75B |
| Total Liabilities | 183.32B | 176.68B | 157.00B | 143.86B | 137.88B | 115.38B |
| Stockholders Equity | 233.90B | 245.23B | 228.67B | 203.95B | 180.42B | 156.88B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.99B | 9.97B | 34.86B | 1.61B | 13.19B |
| Operating Cash Flow | 0.00 | 16.16B | 29.18B | 45.48B | 16.38B | 27.10B |
| Investing Cash Flow | 0.00 | -41.56B | -19.99B | -10.47B | -10.40B | -6.74B |
| Financing Cash Flow | 0.00 | 6.55B | -13.45B | -22.21B | 4.13B | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥1.92T | 14.78 | 6.93% | 3.05% | 4.75% | -24.33% | |
70 Outperform | ¥1.47T | 16.58 | 6.97% | 2.42% | 1.26% | -13.39% | |
63 Neutral | ¥686.51B | 34.91 | 3.63% | 0.67% | 0.25% | -58.68% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥316.90B | 22.88 | ― | 1.92% | 5.66% | -25.08% | |
60 Neutral | $2.54T | 14.43 | 6.47% | 3.23% | 0.86% | 0.55% | |
57 Neutral | ¥295.04B | 24.06 | 8.17% | 1.49% | 4.14% | 9.91% |